DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Operating Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹2,206 Cr | ₹2,369 Cr | ₹3,881 Cr | ₹2,861 Cr | ₹1,823 Cr |
What is the latest Operating Profit of DIVIS LABORATORIES ?
Year | Operating Profit |
---|---|
Mar2024 | ₹2,206 Cr |
Mar2023 | ₹2,369 Cr |
Mar2022 | ₹3,881 Cr |
Mar2021 | ₹2,861 Cr |
Mar2020 | ₹1,823 Cr |
How is Operating Profit of DIVIS LABORATORIES Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹2,206 Cr | -6.88 | |
Mar2023 | ₹2,369 Cr | -38.96 | |
Mar2022 | ₹3,881 Cr | 35.65 | |
Mar2021 | ₹2,861 Cr | 56.92 | |
Mar2020 | ₹1,823 Cr | - |
Compare Operating Profit of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹185,631.0 Cr | 1.8% | 4.8% | 49.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,005.0 Cr | -0.7% | -1.3% | 6.6% | Stock Analytics | |
CIPLA | ₹120,500.0 Cr | -1.1% | -1.3% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,530.0 Cr | 0.6% | 4.2% | 15.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,954.0 Cr | -1.8% | -6% | -1.6% | Stock Analytics | |
MANKIND PHARMA | ₹104,226.0 Cr | 6.9% | 6.2% | 13.7% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 1.8% |
4.8% |
49.8% |
SENSEX | 0.2% |
1.3% |
4.4% |
You may also like the below Video Courses